What is the role of Atarax (hydroxyzine) in treating anxiety?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Role of Hydroxyzine (Atarax) in Treating Anxiety

Hydroxyzine is indicated for short-term symptomatic relief of anxiety and tension associated with psychoneurosis, but its effectiveness for long-term use (beyond 4 months) has not been established by systematic clinical studies. 1

Mechanism and Indications

Hydroxyzine is an antihistamine medication with anxiolytic properties. According to the FDA label, it is approved for:

  • Symptomatic relief of anxiety and tension associated with psychoneurosis
  • As an adjunct in organic disease states with anxiety manifestations
  • Management of pruritus due to allergic conditions
  • As a sedative for premedication 1

Efficacy in Anxiety Treatment

While hydroxyzine has shown efficacy in treating anxiety:

  • It is more effective than placebo for Generalized Anxiety Disorder (GAD) 2
  • Studies have demonstrated good to excellent responses in 54-66% of patients with anxiety 3, 4
  • Early effects on cognitive components of anxiety have been observed from the first week of treatment 5

However, the Cochrane review notes that due to high risk of bias in available studies, small sample sizes, and limited research, hydroxyzine cannot be recommended as a reliable first-line treatment for GAD 2.

Position in Treatment Algorithm

  1. First-line treatments for anxiety disorders should be:

    • SSRIs or SNRIs combined with cognitive behavioral therapy 6
    • Examples include sertraline, escitalopram, venlafaxine, or duloxetine 6
  2. Hydroxyzine's role is primarily as:

    • A short-term adjunctive treatment
    • An alternative when first-line treatments are contraindicated
    • An option for patients with comorbid insomnia due to its sedative properties 6, 5
  3. Benzodiazepines may be considered for short-term relief in patients without history of dependency 6

Dosing Considerations

  • The FDA label does not specify a standard dose for anxiety
  • Clinical trials have used fixed doses of 50 mg with positive results 5
  • Dosing should start low and be adjusted based on response and tolerability

Side Effects and Safety Considerations

Common side effects include:

  • Transitory sleepiness/drowsiness (36% of patients) 3
  • Weakness (18%) 3
  • Headache (6%) 3
  • Dry mouth (2%) 3

Important safety considerations:

  • Hydroxyzine has no dependency potential, unlike benzodiazepines 5
  • No significant organ toxicity has been reported 5
  • Rare allergic reactions may occur 3
  • Potential drug interactions should be monitored, particularly when combined with other CNS depressants
  • Caution is warranted when combining with medications that have alpha-adrenergic antagonist properties, as there is a case report of priapism when hydroxyzine was added to risperidone 7

Use in Special Populations

For children and adolescents:

  • Hydroxyzine (along with diphenhydramine) has been used for management of agitation 8
  • It may be considered as an alternative to antipsychotics or benzodiazepines in certain situations 8
  • However, current guidelines for anxiety disorders in children and adolescents primarily recommend CBT and SSRIs 8

Limitations

  • The effectiveness of hydroxyzine for anxiety beyond 4 months has not been established 1
  • Physicians should periodically reassess the usefulness of the drug for individual patients 1
  • Sedation may limit its use in patients who need to remain alert during the day

Conclusion

While hydroxyzine has demonstrated efficacy for short-term anxiety relief, its role in modern anxiety treatment is primarily as an adjunctive or alternative option rather than first-line therapy. Its favorable safety profile (non-habit forming, minimal organ toxicity) makes it a consideration for specific patient populations, particularly those with comorbid insomnia or when SSRIs/SNRIs are contraindicated.

References

Research

Hydroxyzine for generalised anxiety disorder.

The Cochrane database of systematic reviews, 2010

Research

[Atarax in treatment of anxiety in outpatient clinic].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 1998

Research

Recent clinical trials of hydroxyzine in generalized anxiety disorder.

Acta psychiatrica Scandinavica. Supplementum, 1998

Guideline

Management of Anxiety Disorders

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.